TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25644328

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 205
Study: 23224354

Group type: EXPERIMENTAL
Intervention: Aminophylline (75 mg intravenous)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 20880999

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m² plus gemcitabine 1 gm/m² (group A) on days 1 and 8 every 3 weeks
Number of subjects: 398

Group type: COMPARATOR
Intervention: Paclitaxel 80 mg/m² plus vinorelbine 22.5 mg/m² (group B) on days 1, 8 and 15 every 4 weeks
Number of subjects: 398
Study: 19905891

Group type: EXPERIMENTAL
Intervention: Insulin glargine once-daily
Number of subjects: 973

Group type: COMPARATOR
Intervention: Insulin detemir twice-daily
Number of subjects: 973

Group type: EXPERIMENTAL
Intervention: Insulin glargine once-daily and Insulin detemir twice-daily
Number of subjects: 973
Study: 16846400

Group type: EXPERIMENTAL
Intervention: Tadalafil 20-mg taken 'as needed'
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 10364907

Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 10
Study: 9012182

Group type: EXPERIMENTAL
Intervention: Heated humidifier (HC 100, company Fisher & Paykel)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Heat and moisture exchanger (Typ I, company Dahlhausen)
Number of subjects: 13
Study: 1991906

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6347118

Group type: EXPERIMENTAL
Intervention: Disulfiram (125 mg/day for 7 days, then 250 mg/day for 36 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo and methadone
Number of subjects: 82
Study: 31798025

Group type: EXPERIMENTAL
Intervention: Customized orthopaedic shoes (experimental group)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 73
Study: 29853841

Group type: EXPERIMENTAL
Intervention: Music intervention (MTSZ) for 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-music intervention (UMTSZ) for 1 month
Number of subjects: 0
Study: 25545549

Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate hydrogel (test)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.1% mometasone furoate lotion (reference)
Number of subjects: 90
Study: 24668526

Group type: EXPERIMENTAL
Intervention: Automated detection and quantification of malapposed struts at baseline
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Automated detection and quantification of uncovered struts at follow-up
Number of subjects: 64
Study: 22169682

Group type: EXPERIMENTAL
Intervention: Xience V (everolimus-eluting stent)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Vision (bare-metal stent)
Number of subjects: 140
Study: 20576744

Group type: EXPERIMENTAL
Intervention: SMS intervention group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 17116159

Group type: COMPARATOR
Intervention: 0.2% delmopinol mouth rinse
Number of subjects: 1380
Study: 16253066

Group type: EXPERIMENTAL
Intervention: Bard Inlay stent
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vertex stent
Number of subjects: 44

Group type: COMPARATOR
Intervention: Contour stent
Number of subjects: 44

Group type: COMPARATOR
Intervention: Endo-Sof stent
Number of subjects: 44

Group type: COMPARATOR
Intervention: Classic Double-Pigtail stent
Number of subjects: 44
Study: 12384075

Group type: EXPERIMENTAL
Intervention: Interrupted Donati stitches
Number of subjects: 58

Group type: COMPARATOR
Intervention: Running nylon skin suture
Number of subjects: 58
Study: 10443240

Group type: EXPERIMENTAL
Intervention: Tularemia live vaccine (TLV) immunization given 15-20 days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no preliminary immunization)
Number of subjects: 0
Study: 7756706

Group type: EXPERIMENTAL
Intervention: Gentamicin 6 mg/kg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Gentamicin 2 mg/kg
Number of subjects: 11
Study: 2312449

Group type: EXPERIMENTAL
Intervention: Dihydroxyacetone (DHAP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Polycose (placebo, P)
Number of subjects: 10
Study: 31751790

Group type: EXPERIMENTAL
Intervention: Drained mucosal advancement flap with drainage Seton rerouted around the external anal sphincter
Number of subjects: 97

Group type: COMPARATOR
Intervention: Rerouting Seton around the internal anal sphincter (IAS)
Number of subjects: 97
Study: 29138033

Group type: EXPERIMENTAL
Intervention: High-fidelity simulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-fidelity simulator (coasterlike model)
Number of subjects: 60
Study: 26822630

Group type: EXPERIMENTAL
Intervention: Pioglitazone 7.5 mg daily for 8 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 32
Study: 25160775

Group type: EXPERIMENTAL
Intervention: Upper body musculoskeletal disorders among craft workers (ISCO 7), machine operators (ISCO 8), and workers in elementary occupations (ISCO 9)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower limbs musculoskeletal disorders among service and sales workers (ISCO 5), craft workers (ISCO 7), machine operators (ISCO 8), and workers in elementary occupations (ISCO 9)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical risk factors for both upper body and lower limbs symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standing as a risk factor
Number of subjects: 0
Study: 22232462

Group type: EXPERIMENTAL
Intervention: High-fat breakfast with moxidectin (8 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Fasted subjects with moxidectin (8 mg)
Number of subjects: 54
Study: 20951424

Group type: EXPERIMENTAL
Intervention: RG7128 (1000 mg twice daily) and danoprevir (900 mg twice daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 17949396

Group type: EXPERIMENTAL
Intervention: Murex HIV antigen/antibody combination enzyme immunoassay
Number of subjects: 7333
Study: 16117821

Group type: EXPERIMENTAL
Intervention: Surgical decompression
Number of subjects: 15

Group type: COMPARATOR
Intervention: Methylprednisolone i.v. pulses for 2 weeks followed by oral prednisone for 4 months
Number of subjects: 15
Study: 12098632

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 10425981

Group type: EXPERIMENTAL
Intervention: Lidocaine iontophoresis
Number of subjects: 14

Group type: COMPARATOR
Intervention: Physiologic saline solution iontophoresis (Control)
Number of subjects: 14
Study: 7776110

Group type: EXPERIMENTAL
Intervention: Three doses of synthetic surfactant
Number of subjects: 826

Group type: COMPARATOR
Intervention: One dose of synthetic surfactant
Number of subjects: 826
Study: 2339974

Group type: EXPERIMENTAL
Intervention: Hyoscine (0.6 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sea Band (acupressure band)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 441422

Group type: EXPERIMENTAL
Intervention: Intracervical application of 0.1, 0.2 or 0.3 mg PG‐E2 in 1 ml viscous gel
Number of subjects: 38
Study: 30993400

Group type: EXPERIMENTAL
Intervention: Exercise + fortified milk
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fortified milk
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 31532100

Group type: EXPERIMENTAL
Intervention: Healthy pregnant women (experiment group)
Number of subjects: 1194
Study: 27339709

Group type: EXPERIMENTAL
Intervention: Pilates-based exercises (PE)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combined exercise (CE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Home exercise (HE)
Number of subjects: 55
Study: 25677713

Group type: EXPERIMENTAL
Intervention: Micronutrient-rich snack (containing green leafy vegetables, dried fruit, and whole milk powder)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control snack (containing foods of low micronutrient content such as wheat flour, potato, and tapioca)
Number of subjects: 222
Study: 24004639

Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Low-Intensity Circuit Training (LICT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Endurance Training (ET)
Number of subjects: 58
Study: 21272047

Group type: EXPERIMENTAL
Intervention: Rabeprazole-ER
Number of subjects: 248

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 248

Group type: COMPARATOR
Intervention: Rabeprazole-DR 20 mg
Number of subjects: 248
Study: 19621686

Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy
Number of subjects: 87

Group type: COMPARATOR
Intervention: Transthoracic esophagectomy
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 87
Study: 17259414

Group type: EXPERIMENTAL
Intervention: Cemented femoral component
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hydroxyapatite-coated femoral component
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rotating platform design
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Standard femoral component
Number of subjects: 50
Study: 15134239

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (e.g., warfarin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-vitamin K drugs (warfarin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ximelagatran (direct anti-thrombin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prior anticoagulant treatment before cardioversion
Number of subjects: 0
Study: 11345386

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1094
Study: 10193278

Group type: EXPERIMENTAL
Intervention: Single lung inflation manoeuvre with 100% oxygen before tracheal extubation (group I; n = 59)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Suction through the tube during tracheal extubation (group S; n = 61)
Number of subjects: 120
Study: 7922426

Group type: EXPERIMENTAL
Intervention: Pressure-controlled, inverse-ratio ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized computerized protocols
Number of subjects: 0
Study: 2962712

Group type: EXPERIMENTAL
Intervention: 3% foscarnet cream
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo (cream vehicle)
Number of subjects: 153
Study: 29943624

Group type: EXPERIMENTAL
Intervention: Sorafenib treatment in SHARP eligible patients
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Sorafenib treatment in SHARP non-eligible patients
Number of subjects: 257

Group type: COMPARATOR
Intervention: SHARP ineligibility
Number of subjects: 257
Study: 28207951

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT, 6-8×5 minutes at halfway between lactate threshold and maximal oxygen uptake [50%Δ])
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (CONT, 60-80 minutes at 90% lactate threshold)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 20
Study: 26480664

Group type: EXPERIMENTAL
Intervention: GLP-1 analogue and metformin hydrochloride
Number of subjects: 27

Group type: COMPARATOR
Intervention: Insulin and metformin hydrochloride
Number of subjects: 27
Study: 23461992

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (post‐tetanic count 0‐1)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (at least one response to train‐of‐four nerve stimulation)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 72
Study: 21682834

Group type: EXPERIMENTAL
Intervention: Avandamet (rosiglitazone/metformin)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Metformin (MET)
Number of subjects: 688
Study: 18081360

Group type: EXPERIMENTAL
Intervention: Rouz‐Aciclovir (test)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zovirax (reference)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rouz‐Aciclovir (test) vs Zovirax (reference)
Number of subjects: 12
Study: 17262121

Group type: EXPERIMENTAL
Intervention: Experimental ABF (n=4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (n=4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single Bond etch‐and‐rinse adhesive system (n=4)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 12
Study: 15607401

Group type: EXPERIMENTAL
Intervention: Exercise (90-min treadmill walk)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 20
Study: 11333290

Group type: EXPERIMENTAL
Intervention: Tamoxifen (continued therapy)
Number of subjects: 1172

Group type: COMPARATOR
Intervention: Placebo (discontinued tamoxifen)
Number of subjects: 1172
Study: 9204087

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% gel
Number of subjects: 15

Group type: COMPARATOR
Intervention: Tretinoin 0.025% gel
Number of subjects: 15
Study: 7704288

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg b.i.d for 6 weeks)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3297214

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30446878

Group type: EXPERIMENTAL
Intervention: T2D genetic risk score (GRS) using 34 T2D risk genetic variants
Number of subjects: 11506

Group type: EXPERIMENTAL
Intervention: T2D_GRS as the IV
Number of subjects: 11506

Group type: EXPERIMENTAL
Intervention: Combined effect of the genetic IVs for T2D
Number of subjects: 11506

Group type: EXPERIMENTAL
Intervention: T2D and depression with IVW after excluding pleiotropic SNPs
Number of subjects: 11506
Study: 27719686

Group type: EXPERIMENTAL
Intervention: 2'-O-fucosyllactose (2'FL) and/or lacto-N-neotetraose (LNnT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24115478

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) administered chairside during dialysis for 3 months
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 59
Study: 23878604

Group type: EXPERIMENTAL
Intervention: Once-weekly yoga classes (n = 49)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Twice-weekly yoga classes (n = 46)
Number of subjects: 95
Study: 21159050

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) combined with donepezil, 30-minute sessions weekly for 7 weeks.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group receiving only donepezil.
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CST group (donepezil + CST)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (donepezil only)
Number of subjects: 49
Study: 18783960

Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 82

Group type: COMPARATOR
Intervention: Shuntless group
Number of subjects: 82
Study: 16636038

Group type: EXPERIMENTAL
Intervention: Airway Cam
Number of subjects: 27
Study: 12740229

Group type: EXPERIMENTAL
Intervention: Dopexamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 0
Study: 10340371

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 7727669

Group type: EXPERIMENTAL
Intervention: Topical formulation (15% paromomycin sulfate/5% methylbenzethonium chloride, twice a day) and injectable meglumine antimonate (20 mg of antimony [Sb]/kg.d) for 10 days and 7 days respectively
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Topical formulation (15% paromomycin sulfate/5% methylbenzethonium chloride, twice a day) and injectable meglumine antimonate (20 mg of antimony [Sb]/kg.d) for 10 days and 3 days respectively
Number of subjects: 39

Group type: COMPARATOR
Intervention: Injectable meglumine antimonate (Sb) alone for 10-15 days (historical controls)
Number of subjects: 39
Study: 2523657

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 to 7.5 mg twice daily)
Number of subjects: 23
Study: 127945

Group type: EXPERIMENTAL
Intervention: Aqueous procaine penicillin G, 4.8 million units intramuscularly plus 1 g of oral probenecid
Number of subjects: 9008

Group type: COMPARATOR
Intervention: Ampicillin-probenecid
Number of subjects: 9008

Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 9008

Group type: COMPARATOR
Intervention: Spectinomycin
Number of subjects: 9008
Study: 30395314

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 30858230

Group type: EXPERIMENTAL
Intervention: Low-trigger group (hemoglobin < 8.0 g/dL)
Number of subjects: 58

Group type: COMPARATOR
Intervention: High-trigger group (hemoglobin < 9.7 g/dL)
Number of subjects: 58
Study: 28698268

Group type: EXPERIMENTAL
Intervention: PSV+VG
Number of subjects: 42

Group type: COMPARATOR
Intervention: SIMV+VG
Number of subjects: 42
Study: 25867874

Group type: EXPERIMENTAL
Intervention: Morphine infusion 0.02 mg/kg/h after 0.1 mg/kg iv bolus
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion 0.25 µg/kg/min following 1 µg/kg iv bolus
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Alfentanil infusion 0.50 µg/kg/min following 10 µg/kg iv bolus
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline 5 cc iv bolus and 10 cc/h infusion for induction and maintenance
Number of subjects: 60
Study: 23777510

Group type: EXPERIMENTAL
Intervention: 3-month period of auto-titrating CPAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 22389988

Group type: EXPERIMENTAL
Intervention: Nebulized epinephrine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 75
Study: 19018449

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17485570

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/metformin 2,000 mg (S100/M2000)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/metformin 1,000 mg (S100/M1000)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Metformin 2,000 mg (M2000)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Metformin 1,000 mg (M1000)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg (S100)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/metformin 2,000 mg (S100/M2000) in open-label cohort
Number of subjects: 1091

Group type: COMPARATOR
Intervention: All active treatment groups
Number of subjects: 1091

Group type: COMPARATOR
Intervention: Co-administration therapies vs respective metformin monotherapy
Number of subjects: 1091
Study: 15447957

Group type: EXPERIMENTAL
Intervention: Portal perfusion without compensation for respiratory misregistration
Number of subjects: 43

Group type: COMPARATOR
Intervention: Portal perfusion with compensation for respiratory misregistration
Number of subjects: 43

Group type: COMPARATOR
Intervention: Patients with chronic hepatitis
Number of subjects: 43

Group type: COMPARATOR
Intervention: Patients with liver cirrhosis
Number of subjects: 43

Group type: COMPARATOR
Intervention: Patients with normal liver
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Portal perfusion in liver tumour patients
Number of subjects: 43
Study: 11243908

Group type: EXPERIMENTAL
Intervention: Indenter head size 300mm² at 0.25 Hz
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Indenter head size 720mm² at 0.5 Hz
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Indenter head size 1564mm² at 2 Hz
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fast testing frequency (2 Hz)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Small indenter heads at slow speed (0.25 Hz)
Number of subjects: 36
Study: 9526964

Group type: EXPERIMENTAL
Intervention: Sibutramine 30 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7993330

Group type: EXPERIMENTAL
Intervention: Behavioral treatment (stimulus control, urge control, contracting/family support, competing response procedures) for an average of 19 sessions
Number of subjects: 82

Group type: COMPARATOR
Intervention: Supportive treatment (alternative treatment)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 82
Study: 2951426

Group type: EXPERIMENTAL
Intervention: Ordinary dosage of ipratropium (80 micrograms four times a day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-dose therapy of ipratropium (400 micrograms four times a day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29311299

Group type: EXPERIMENTAL
Intervention: Group malleability intervention
Number of subjects: 508

Group type: COMPARATOR
Intervention: Neutral coping intervention
Number of subjects: 508

Group type: COMPARATOR
Intervention: Perspective-taking intervention
Number of subjects: 508
Study: 27823683

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (12 weeks physical exercise and four psycho-educational consultations)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 210
Study: 25355680

Group type: EXPERIMENTAL
Intervention: Adjuvant procarbazine, CCNU, and vincristine (PCV) chemotherapy after 54 Gy of radiotherapy (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 54 Gy of radiotherapy (RT) alone
Number of subjects: 0
Study: 23193678

Group type: EXPERIMENTAL
Intervention: Qianlieping Capsule plus tamsulosin
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Qianlieping Capsule alone
Number of subjects: 220

Group type: COMPARATOR
Intervention: Tamsulosin alone
Number of subjects: 220
Study: 20360500

Group type: EXPERIMENTAL
Intervention: Long gamma nail
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sliding hip screw
Number of subjects: 210
Study: 18263885

Group type: EXPERIMENTAL
Intervention: Conscious hypnosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Verbal motivation by orthodontist (Control)
Number of subjects: 30